Opaleye Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-480,000
Closed -$1.56M 48
2024
Q3
$1.56M Sell
480,000
-120,000
-20% -$389K 0.26% 37
2024
Q2
$1.8M Sell
600,000
-159,000
-21% -$477K 0.41% 42
2024
Q1
$3.53M Sell
759,000
-118,000
-13% -$549K 0.77% 33
2023
Q4
$3.63M Buy
877,000
+847,000
+2,823% +$3.51M 0.97% 25
2023
Q3
$90K Buy
+30,000
New +$90K 0.03% 40